Skip to main content
TipRanks
Go Ultimate75% OFF

Cellebrite DI (CLBT) Financial Statements

605 Followers

Cellebrite DI Financial Overview

Cellebrite DI's market cap is currently $2.68B. The company's EPS TTM is $0.26; its P/E ratio is 39.89; Cellebrite DI is estimated to report earnings on February 17, 2027, and the estimated EPS forecast is $0.11. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 475.68M$ 401.20M$ 325.11M$ 270.65M$ 246.25M
Gross Profit$ 400.50M$ 338.61M$ 271.88M$ 219.91M$ 203.69M
Operating Income$ 66.48M$ 56.91M$ 33.24M$ 1.04M$ 13.82M
EBITDA$ 103.07M$ -265.35M$ -65.41M$ 130.10M$ 89.47M
Net Income$ 78.33M$ -283.01M$ -81.10M$ 120.81M$ 71.40M
Balance Sheet
Cash & Short-Term Investments$ 437.05M$ 447.22M$ 302.92M$ 183.62M$ 181.56M
Total Assets$ 938.85M$ 690.57M$ 532.88M$ 403.29M$ 339.78M
Total Debt$ 22.67M$ 10.97M$ 14.13M$ 15.36M$ 0.00
Net Debt$ -101.79M$ -180.69M$ -175.39M$ -72.29M$ -145.97M
Total Liabilities$ 454.53M$ 354.55M$ 498.67M$ 329.43M$ 413.13M
Stockholders' Equity$ 484.32M$ 336.02M$ 34.21M$ 73.86M$ -73.35M
Cash Flow
Free Cash Flow$ 155.73M$ 121.56M$ 94.14M$ 11.49M$ 27.94M
Operating Cash Flow$ 168.96M$ 132.17M$ 102.06M$ 20.58M$ 36.05M
Investing Cash Flow$ -268.25M$ -149.47M$ -22.54M$ -91.23M$ 45.23M
Financing Cash Flow$ 29.64M$ 20.65M$ 21.77M$ 13.97M$ -68.40M

Currency in USD

Cellebrite DI Earnings and Revenue History

-400M0400M800M-120 %-60 %0 %60 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

Cellebrite DI Liabilities to Assets

0400M800M1.2B40 %80 %120 %160 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Cellebrite DI Cash Flow

-300M-200M-100M0100M200M2019202020212022202320242025OperatingInvestingFinancing

Cellebrite DI Forecast EPS vs Actual EPS

000.10.10.10.1Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss